Evidence map›Paper›PMID 34722334›Full record

ArticleFrontiers in cellular and infection microbiology2021

Emergence of ST63 Pandrug-Resistant

Ling Yang, Ning Dong, Chen Xu, Lianwei Ye, Sheng Chen

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Identification and functional characterization of a novelFrontiers in cellular and infection microbiology · 2025
    Article
  2. Article
  3. Article
  4. Frontiers in microbiology · 2024
    Article
  5. Emergence of a ST248Infection and drug resistance · 2023
    Article
  6. Article
  7. GR13-type plasmids inMicrobial genomics · 2022
    Article
  8. Emergence of uncommon KL38-OCL6-ST220 carbapenem-resistantFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ling YangDepartment of Laboratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Ning DongDepartment of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong, Hong Kong, SAR, China.
Chen XuDepartment of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong, Hong Kong, SAR, China.
Lianwei YeDepartment of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong, Hong Kong, SAR, China.
Sheng ChenDepartment of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong, Hong Kong, SAR, China.
City University of Hong Kong · HKGuangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcinetobacterAcinetobacter baumanniiAcinetobacter InfectionsPulmonary Disease, Chronic ObstructiveAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesChinaHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesAcinetobacter pittiiAECOPDblaOXA-58pandrug-resistancepoint mutationswhole genome sequencing

Identifiers

PMID34722334
PMCPMC8552005
OpenAlexW3207391462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.